Top Clinical Trials companies in Canada by Net Income Margin
Canada
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
96.32%
|
Dec. 31, 2023 | USD 9.51 | -0.80% |
|
Canada |
|
| 2 |
-0.19%
|
March 31, 2024 | USD 2.65 | -1.93% |
|
Canada |
|
| 3 |
-5.13%
|
Dec. 31, 2023 | USD 4.00 | 3.39% |
|
Canada |
|
| 4 |
-29.30%
|
Nov. 30, 2023 | USD 1.52 | 2.02% |
|
Canada |
|
| 5 |
-43.65%
|
Dec. 31, 2023 | USD 2.96 | 1.10% |
|
Canada |
|
| 6 |
-44.45%
|
Dec. 31, 2023 | USD 7.95 | -0.62% |
|
Canada |
|
| 7 |
-156.13%
|
Dec. 31, 2023 | USD 14.60 | -0.95% |
|
Canada |
|
| 8 |
-183.44%
|
Dec. 31, 2023 | USD 1.22 | 2.52% |
|
Canada |
|
| 9 |
-385.00%
|
Dec. 31, 2023 | USD 3.17 | -1.86% |
|
Canada |
|
| 10 |
-396.85%
|
Dec. 31, 2023 | USD 6.23 | -0.19% |
|
Canada |
|
| 11 |
-5,968.50%
|
Dec. 31, 2023 | USD 1.97 | -2.48% |
|
Canada |
Frequently Asked Questions
-
Which Clinical Trials company in Canada has the highest Net Income Margin ?
The Clinical Trials company in Canada with the highest Net Income Margin is Cipher Pharmaceuticals Inc. (Toronto Stock Exchange: CPH.TO) at 96.32%.
-
Which Clinical Trials company in Canada has the lowest Net Income Margin ?
The Clinical Trials company in Canada with the lowest Net Income Margin is Milestone Pharmaceuticals Inc. (NasdaqGS: MIST) at -5,968.50%.
-
What are the top 10 Clinical Trials companies in Canada by Net Income Margin ?
The top 10 Clinical Trials companies in Canada by Net Income Margin are Cipher Pharmaceuticals Inc., Medexus Pharmaceuticals Inc., Knight Therapeutics Inc., Theratechnologies Inc., HLS Therapeutics Inc., Aurinia Pharmaceuticals Inc., Zymeworks Inc., Repare Therapeutics Inc., AbCellera Biologics Inc. and Profound Medical Corp..
-
What are the bottom 10 Clinical Trials companies in Canada by Net Income Margin ?
The bottom 10 Clinical Trials companies in Canada by Net Income Margin are Milestone Pharmaceuticals Inc., Profound Medical Corp., AbCellera Biologics Inc., Repare Therapeutics Inc., Zymeworks Inc., Aurinia Pharmaceuticals Inc., HLS Therapeutics Inc., Theratechnologies Inc., Knight Therapeutics Inc. and Medexus Pharmaceuticals Inc..
